Related Experiment Video
Updated: May 2, 2026

12:28
Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments
Published on: October 15, 2016
13.7K
In vitro Fab display: a cell-free system for IgG discovery
Ryan L Stafford1, Marissa L Matsumoto, Gang Yin
1Sutro Biopharma, Inc., 310 Utah Ave Suite 150, South San Francisco, CA 94080, USA.
Protein Engineering, Design & Selection : PEDS
|March 4, 2014
Summary
This study introduces a novel cell-free method for selecting multi-chain antibody fragments, like Fab fragments, using ribosome display. This breakthrough enables the discovery of new antibody therapeutics targeting diseases like cancer.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- Ribosome display is a powerful in vitro selection technology for discovering novel antibody fragments.
- Current ribosome display methods are limited to selecting single-chain protein fragments due to the open nature of cell-free reactions.
Purpose of the Study:
- To develop a simplified ribosome display approach for selecting multi-chain protein fragments, specifically antibody Fab fragments.
- To demonstrate the feasibility of generating functional antibody Fab fragments using this novel cell-free selection method.
Main Methods:
- A modified ribosome display system was developed to tether either the heavy or light chain of a two-chain antibody Fab fragment to the ribosome.
- Synthetic Fab heavy and light chain libraries were constructed and selected against carcinoembryonic antigen (CEA) and vascular endothelial growth factor (VEGF).
- Selected Fab fragments were reformatted into full-length immunoglobulin Gs (IgGs) and expressed in an optimized cell-free system for characterization.
Main Results:
- The developed method successfully displayed functional antibody Fab fragments, retaining antigen-binding capabilities.
- Novel antibody Fab fragments targeting CEA and VEGF were identified through selection against these antigens.
- The selected antibody fragments were successfully converted into full-length IgGs and expressed in a cell-free system, enabling rapid screening and characterization.
Conclusions:
- This cell-free platform offers a streamlined approach for the selection and discovery of multi-chain antibody fragments, including Fab fragments.
- The method facilitates the rapid generation of novel antibody therapeutics, such as IgGs, targeting specific antigens like CEA and VEGF.
- This technique expands the utility of ribosome display for antibody engineering and drug discovery.

